tiprankstipranks
FibroBiologics, Inc. (FBLG)
NASDAQ:FBLG
US Market
FBLG
FibroBiologics, Inc.
RESEARCH TOOLSreports
Want to see FBLG full AI Analyst Report?

FibroBiologics, Inc. (FBLG) Income Statement

252 Followers

FibroBiologics, Inc. Income Statement

Last quarter (Q1 2026), FibroBiologics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, FibroBiologics, Inc.'s net income was $-5.00M. See FibroBiologics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -832.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 15.82M$ 13.74M$ 8.89M$ 4.47M$ 1.58M
Depreciation and Amortization
$ 832.00K$ 573.00K$ 437.00K$ 94.00K$ 0.00
EBITDA
$ -17.61M$ -10.57M$ -15.90M$ -4.37M$ -1.58M
Operating Income
$ -16.65M$ -13.74M$ -8.89M$ -4.47M$ -1.58M
Other Income/Expenses
$ -2.00M$ 2.58M$ -7.60M$ -654.00K$ -4.00K
Pretax Income
$ -18.65M$ -11.16M$ -16.48M$ -5.12M$ -1.58M
Net Income
$ -18.65M$ -11.16M$ -16.48M$ -5.12M$ -1.58M
Per Share Metrics
Basic EPS
$ -8.40$ -6.80$ -11.80$ -3.20$ -0.97
Diluted EPS
$ -8.40$ -6.80$ -11.80$ -3.20$ -0.97
Weighted Average Shares Outstanding
 2.23M 1.64M 1.62M 1.62M 1.62M
Weighted Average Shares Outstanding (Diluted)
 2.23M 1.64M 1.62M 1.62M 1.62M
Currency in USD

FibroBiologics, Inc. Earnings and Revenue History